These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
284 related items for PubMed ID: 22467424
1. Development of a novel self-dissolving microneedle array of alendronate, a nitrogen-containing bisphosphonate: evaluation of transdermal absorption, safety, and pharmacological effects after application in rats. Katsumi H, Liu S, Tanaka Y, Hitomi K, Hayashi R, Hirai Y, Kusamori K, Quan YS, Kamiyama F, Sakane T, Yamamoto A. J Pharm Sci; 2012 Sep; 101(9):3230-8. PubMed ID: 22467424 [Abstract] [Full Text] [Related]
2. Development of a novel transdermal patch of alendronate, a nitrogen-containing bisphosphonate, for the treatment of osteoporosis. Kusamori K, Katsumi H, Abe M, Ueda A, Sakai R, Hayashi R, Hirai Y, Quan YS, Kamiyama F, Sakane T, Yamamoto A. J Bone Miner Res; 2010 Dec; 25(12):2582-91. PubMed ID: 20533374 [Abstract] [Full Text] [Related]
3. Efficient Transdermal Delivery of Alendronate, a Nitrogen-Containing Bisphosphonate, Using Tip-Loaded Self-Dissolving Microneedle Arrays for the Treatment of Osteoporosis. Katsumi H, Tanaka Y, Hitomi K, Liu S, Quan YS, Kamiyama F, Sakane T, Yamamoto A. Pharmaceutics; 2017 Aug 17; 9(3):. PubMed ID: 28817072 [Abstract] [Full Text] [Related]
4. [Development of a novel transdermal delivery system of alendronate, a nitrogen containing bisphosphonate, using a new type of hydrophilic patch and dissolving microneedle arrays]. Katsumi H. Yakugaku Zasshi; 2014 Aug 17; 134(3):427-31. PubMed ID: 24584024 [Abstract] [Full Text] [Related]
8. Absorption and safety of alendronate, a nitrogen-containing bisphosphonate, after intrapulmonary administration in rats. Katsumi H, Nakatani M, Sano J, Abe M, Kusamori K, Kurihara M, Shiota R, Takashima M, Fujita T, Sakane T, Hibi T, Yamamoto A. Int J Pharm; 2010 Nov 15; 400(1-2):124-30. PubMed ID: 20816731 [Abstract] [Full Text] [Related]
10. Ultrasound-assisted transdermal delivery of alendronate for the treatment of osteoporosis. Li B, Huang G, Ma Z, Qin S. Acta Biochim Pol; 2020 Jun 19; 67(2):173-179. PubMed ID: 32558528 [Abstract] [Full Text] [Related]
12. Permeation of sumatriptan succinate across human skin using multiple types of self-dissolving microneedle arrays fabricated from sodium hyaluronate. Wu D, Katsumi H, Quan YS, Kamiyama F, Kusamori K, Sakane T, Yamamoto A. J Drug Target; 2016 Sep 19; 24(8):752-8. PubMed ID: 26878569 [Abstract] [Full Text] [Related]
13. Evaluating two nanocarrier systems for the transdermal delivery of sodium alendronate. Villanueva-Martínez A, Hernández-Rizo L, Ganem-Rondero A. Int J Pharm; 2020 May 30; 582():119312. PubMed ID: 32278052 [Abstract] [Full Text] [Related]
20. Effect of applying modes of the polymer microneedle-roller on the permeation of L-ascorbic acid in rats. You SK, Noh YW, Park HH, Han M, Lee SS, Shin SC, Cho CW. J Drug Target; 2010 Jan 15; 18(1):15-20. PubMed ID: 19622020 [Abstract] [Full Text] [Related] Page: [Next] [New Search]